biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > So, what do I think? Or say?

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Feb 20, 2021 2:10am

142 Views

Post# 32617681

RE:RE:So, what do I think? Or say?

Thank you, 944. You are, indeed, my friend. You and I are going to have an interesting F1 season to talk about, and maybe some excellent Bioasis stuff to talk about, as well.

Don't know about you, but I'm all in for McLaren, and also for Sergio Perez at Red Bull. After what he's gone through, and how well he's driven, I liken him to Bioasis, down, but absolutely in the race.

Chat soon, buddy.

jd

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?